Screener
Madrigal Pharmaceuticals, Inc. MDGL Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Madrigal Pharmaceuticals, Inc.’s reported figures.
Based on the most recent quarter.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s current ratio?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported current ratio of 3.2× in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s current ratio changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s current ratio decreased by 37.2% year-over-year, from 5.1× to 3.2×.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s current ratio has grown at a -8.1% compound annual growth rate (CAGR), from 6.1× to 4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude